Soligenix News - SNGX

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Soligenix Inc SNGX NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0248 -2.58% 0.9365 0.98 0.9015 0.96 0.9613 17:59:46
more quote information »

Recent News

Date Time Source Heading
11/12/201916:15EDGARQuarterly Report (10-q)
11/12/201907:00PRNUSSoligenix Announces Recent Accomplishments And Third Quarter..
11/06/201907:00PRNUSSoligenix to Present at the 25th Annual BIO-Europe..
10/24/201907:00PRNUSSoligenix Receives US Patent for Improved Production of..
10/18/201916:35EDGARCurrent Report Filing (8-k)
10/03/201907:00PRNUSSoligenix to Present at the 20th Annual GCFF Investor..
9/23/201919:16EDGARStatement of Changes in Beneficial Ownership (4)
9/23/201916:19EDGARStatement of Changes in Beneficial Ownership (4)
9/17/201907:00EDGARCurrent Report Filing (8-k)
9/16/201907:00PRNUSSoligenix Appoints Daniel P. Ring as Vice President of..
9/11/201916:18EDGARStatement of Changes in Beneficial Ownership (4)
9/11/201916:17EDGARInitial Statement of Beneficial Ownership (3)
9/11/201916:16EDGARCurrent Report Filing (8-k)
9/11/201907:00PRNUSSoligenix Appoints Jonathan Guarino as Chief Financial..
9/10/201918:42EDGARStatement of Changes in Beneficial Ownership (4)
9/10/201918:41EDGARStatement of Changes in Beneficial Ownership (4)
9/10/201918:39EDGARStatement of Changes in Beneficial Ownership (4)
9/10/201918:39EDGARStatement of Changes in Beneficial Ownership (4)
9/10/201918:38EDGARStatement of Changes in Beneficial Ownership (4)
8/29/201916:31EDGARCurrent Report Filing (8-k)
8/29/201907:00PRNUSSoligenix to Present at the RHK Capital 2019 Disruptive..
8/28/201907:00PRNUSSoligenix Announces Positive Recommendation by Independent..
8/15/201907:00PRNUSSoligenix Announces $150,000 NIH Small Business Innovation..
8/13/201916:17EDGARQuarterly Report (10-q)
8/13/201907:00PRNUSSoligenix Announces Recent Accomplishments And Second..
7/31/201916:19EDGARCurrent Report Filing (8-k)
7/31/201907:00PRNUSSoligenix Announces Conference Presentations Demonstrating..
7/29/201907:00PRNUSSoligenix Receives European Patents for Oral BDP in the..
7/26/201916:20EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/26/201916:17EDGARProxy Statement (definitive) (def 14a)
7/10/201917:22EDGARStatement of Changes in Beneficial Ownership (4)
7/09/201906:02EDGARCurrent Report Filing (8-k)
7/08/201919:52EDGARStatement of Changes in Beneficial Ownership (4)
7/08/201907:00PRNUSSoligenix Announces Appointment of Diane L. Parks to its..
6/13/201907:00PRNUSSoligenix to Present RiVax® Program at the 13ᵗʰ Annual..
5/28/201907:00PRNUSSoligenix Announces $600,000 Subaward Supporting Evaluation..
5/14/201916:32EDGARQuarterly Report (10-q)
5/14/201907:00PRNUSSoligenix Announces Recent Accomplishments And First Quarter..
4/23/201916:18EDGARCurrent Report Filing (8-k)
4/23/201907:00PRNUSSoligenix -- Advancing to Important Inflection Points With..
4/22/201916:42EDGARStatement of Changes in Beneficial Ownership (4)
4/22/201916:42EDGARStatement of Changes in Beneficial Ownership (4)
4/18/201907:00PRNUSSoligenix Achieves Significant Enrollment Milestone for its..
4/15/201907:00PRNUSSoligenix Receives $611,000 in Non-Dilutive Funding Through..
4/09/201907:00PRNUSSoligenix and the European Medicines Agency Pediatric..
4/04/201907:00PRNUSSoligenix Receives US Patent for Dusquetide Related Analogs
3/26/201916:38EDGARAnnual Report (10-k)
3/26/201907:00PRNUSSoligenix Announces Recent Accomplishments and Year-End 2018..
3/18/201907:00PRNUSSoligenix to Present at National Institutes of Health -..
3/15/201916:21EDGARCurrent Report Filing (8-k)
See more news about this stock »

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.